• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.63 $0.02 (0.15%)

REAL-TIME: Last trade at

Anika Therapeutics, Inc.

NASDAQ:ANIK

Anika Therapeutics: A Bio-Pharma Poised For Long Term Gains

Anika Therapeutics falls 13.3%

Anika Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Anika Therapeutics gaps down below its 10-day MA, support at $14.39

Anika Therapeutics Reports Record First-Quarter Revenue and Earnings

Anika Therapeutics, Inc. (ANIK) Misses Q1 EPS by 3c

Anika Therapeutics reports Q1 EPS 14c, one estimate 17c

Anika Therapeutics Announces Date of First-Quarter 2012 Financial Results Conference Call

Anika Therapeutics Announces Date of First-Quarter 2012 Financial Results Conference Call

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

3 New Biotech Buys for Your Portfolio

Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Anika Therapeutics price target raised to $16 from $12 at Summer Street

Anika Therapeutics Reports 25% Increase in Fourth-Quarter Revenue

Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21

Anika Therapeutics reports Q4 EPS 21c, consensus 13c

Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2011 Financial Results Conference Call

Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on February 7

Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on February 7

Anika Therapeutics to Present at the Eighth Annual Noble Financial Equity Conference on January 17

Anika Therapeutics to Present at the Eighth Annual Noble Financial Equity Conference on January 17

Anika Therapeutics - What's Up Next?

Anika Therapeutics price target raised to $12 from $9 at Summer Street

Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc.

Anika Therapeutics signs U.S. license and supply agreement with DePuy Mitek

Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc.

Anika Therapeutics to Present at the LD Micro Conference on December 8

Anika Therapeutics to Present at the LD Micro Conference on December 8

Anika Therapeutics initiated with a Buy at Sidoti

Anika Therapeutics to Present at the Security Research Associates 7th Annual Fall Growth Stock Conference on November 15

Anika Therapeutics to Present at the Security Research Associates 7th Annual Fall Growth Stock Conference on November 15

Anika Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011

Anika Therapeutics Announces Date of Third-Quarter 2011 Financial Results Conference Call

Anika Therapeutics Announces Date of Third-Quarter 2011 Financial Results Conference Call

Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12

Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12

Internationally Recognized Scientist Returns to Anika Therapeutics, Inc.

Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript

Anika Therapeutics Reports Second-Quarter 2011 Financial Results

See More Articles...